Z-2152-2025 Class II Ongoing
FDA device recall Z-2152-2025 was initiated by Beckman Coulter Inc. on Jun 12, 2025 and is designated Class II. Reason for recall: A specific lot of bovine serum albumin (BSA) used for manufacturing of coated tubes (CT) that are included in the Estrone RIA kit lots caused different affinity of manufactured coated tubes to patient… The recall status is ongoing. Affected quantity: 496 units.
Recall details
- Product Type
- Devices
- Report Date
- Jul 30, 2025
- Initiation Date
- Jun 12, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 496 units
Product description
Estrone RIA, REF: DSL8700. Estrone RIA is an IVD used for the quantitative measurement of estrone in human serum and plasma.
Reason for recall
A specific lot of bovine serum albumin (BSA) used for manufacturing of coated tubes (CT) that are included in the Estrone RIA kit lots caused different affinity of manufactured coated tubes to patient samples, causing falsely increased assay results for the impacted Estrone RIA kits.
Distribution pattern
US: North Carolina OUS: Argentina, Austria, Belgium, Canada, France, Germany, Greece, Hungary, Italy, Netherlands
Code information
UDI: 15099590211615/Lot: 250106D, 250203C, 250203D, 250303C, 250331C, 250428C, 250526C
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2152-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026